Long-term results in combined-modality treatment of small cell carcinoma of the lung

Lawrence Einhorn, W. H. Bond, N. Hornback, B. T. Joe

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Fifty-eight patients with small cell carcinoma of the lung were treated with a combined-modality regimen: chemotherapy with adriamycin, cyclophosphamide, and vincristine; BCG immunotherapy; radiotherapy to the lung primary and prophylactic cranial irradiation. Nineteen patients had limited disease, and 39 had extensive disease. There were 27 (48%) partial remissions and 23 (41%) complete remissions, and median survival was 51 wk. Initial performance status and extent of disease had a definite effect on survival. Only 1 patient developed CNS metastases on prophylactic cranial irradiation. Five of 19 patients (26%) with limited disease remain alive and in complete remission at 26-45+ mo. It is becoming clear from this and other recent studies that we can significantly prolong median survival in small cell lung cancer. However, even more important is the fact that limited-extent small cell lung cancer may be a potentially curable disease.

Original languageEnglish
Pages (from-to)309-313
Number of pages5
JournalSeminars in Oncology
Volume5
Issue number3
StatePublished - 1978

Fingerprint

Small Cell Lung Carcinoma
Cranial Irradiation
Survival
Therapeutics
Vincristine
Mycobacterium bovis
Immunotherapy
Doxorubicin
Cyclophosphamide
Radiotherapy
Neoplasm Metastasis
Drug Therapy
Lung

ASJC Scopus subject areas

  • Oncology

Cite this

Long-term results in combined-modality treatment of small cell carcinoma of the lung. / Einhorn, Lawrence; Bond, W. H.; Hornback, N.; Joe, B. T.

In: Seminars in Oncology, Vol. 5, No. 3, 1978, p. 309-313.

Research output: Contribution to journalArticle

Einhorn, Lawrence ; Bond, W. H. ; Hornback, N. ; Joe, B. T. / Long-term results in combined-modality treatment of small cell carcinoma of the lung. In: Seminars in Oncology. 1978 ; Vol. 5, No. 3. pp. 309-313.
@article{1ed090b7f1194b92adbcee8015f7ee8f,
title = "Long-term results in combined-modality treatment of small cell carcinoma of the lung",
abstract = "Fifty-eight patients with small cell carcinoma of the lung were treated with a combined-modality regimen: chemotherapy with adriamycin, cyclophosphamide, and vincristine; BCG immunotherapy; radiotherapy to the lung primary and prophylactic cranial irradiation. Nineteen patients had limited disease, and 39 had extensive disease. There were 27 (48{\%}) partial remissions and 23 (41{\%}) complete remissions, and median survival was 51 wk. Initial performance status and extent of disease had a definite effect on survival. Only 1 patient developed CNS metastases on prophylactic cranial irradiation. Five of 19 patients (26{\%}) with limited disease remain alive and in complete remission at 26-45+ mo. It is becoming clear from this and other recent studies that we can significantly prolong median survival in small cell lung cancer. However, even more important is the fact that limited-extent small cell lung cancer may be a potentially curable disease.",
author = "Lawrence Einhorn and Bond, {W. H.} and N. Hornback and Joe, {B. T.}",
year = "1978",
language = "English",
volume = "5",
pages = "309--313",
journal = "Seminars in Oncology",
issn = "0093-7754",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Long-term results in combined-modality treatment of small cell carcinoma of the lung

AU - Einhorn, Lawrence

AU - Bond, W. H.

AU - Hornback, N.

AU - Joe, B. T.

PY - 1978

Y1 - 1978

N2 - Fifty-eight patients with small cell carcinoma of the lung were treated with a combined-modality regimen: chemotherapy with adriamycin, cyclophosphamide, and vincristine; BCG immunotherapy; radiotherapy to the lung primary and prophylactic cranial irradiation. Nineteen patients had limited disease, and 39 had extensive disease. There were 27 (48%) partial remissions and 23 (41%) complete remissions, and median survival was 51 wk. Initial performance status and extent of disease had a definite effect on survival. Only 1 patient developed CNS metastases on prophylactic cranial irradiation. Five of 19 patients (26%) with limited disease remain alive and in complete remission at 26-45+ mo. It is becoming clear from this and other recent studies that we can significantly prolong median survival in small cell lung cancer. However, even more important is the fact that limited-extent small cell lung cancer may be a potentially curable disease.

AB - Fifty-eight patients with small cell carcinoma of the lung were treated with a combined-modality regimen: chemotherapy with adriamycin, cyclophosphamide, and vincristine; BCG immunotherapy; radiotherapy to the lung primary and prophylactic cranial irradiation. Nineteen patients had limited disease, and 39 had extensive disease. There were 27 (48%) partial remissions and 23 (41%) complete remissions, and median survival was 51 wk. Initial performance status and extent of disease had a definite effect on survival. Only 1 patient developed CNS metastases on prophylactic cranial irradiation. Five of 19 patients (26%) with limited disease remain alive and in complete remission at 26-45+ mo. It is becoming clear from this and other recent studies that we can significantly prolong median survival in small cell lung cancer. However, even more important is the fact that limited-extent small cell lung cancer may be a potentially curable disease.

UR - http://www.scopus.com/inward/record.url?scp=0018118221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018118221&partnerID=8YFLogxK

M3 - Article

C2 - 211642

AN - SCOPUS:0018118221

VL - 5

SP - 309

EP - 313

JO - Seminars in Oncology

JF - Seminars in Oncology

SN - 0093-7754

IS - 3

ER -